Warning of the European Agency for the Evaluation of Medicinal Products (EMEA) regarding antidepressant use in children and adolescents: Comment and recommendation from a child and adolescent psychiatry perspective;Warnung der arzneimittelbehörde zur anwendung von antidepressiva bei kindern und jugendlichen: Kommentar und empfehlung aus kinder- und jugendpsychiatrischer sicht

Neuropsychiatrie

Volumn 20, Issue 2, 2006, Pages 135-136

  Klier, Claudia M ^a   Karwautz, Andreas ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Adolescents; Children; Depression; SSRI; Suicidality

Indexed keywords

ANTIDEPRESSANT AGENT;

AUSTRIA; CHILD HEALTH CARE; CHILD PSYCHIATRY; DEPRESSION; DRUG SAFETY; DRUG USE; EUROPE; HUMAN; MEDICAL PRACTICE; PATIENT CARE; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; TREATMENT PLANNING;

EID: 33746631625     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (4)

1. Licinio J., Wong M: Depression, antidepressants and suicidality: a critical appraisal. Nature Reviews 4, 165-171
2. Ramchandani P: Treatment of major depressive disorder in children and adolescents. BMJ 328:3-4 (2004)
3. Olfson M., Shaffer D., Marcus SC., Greenberg T: Relationship between anti-depressant medication treatment and suicide in adolescents. Arch Gen Psychiatry 60(10):978-8 (2003)
4. Aichhorn A. W., Geretsegger Ch.: Sicherheit und Wirksamkeit von Serotonin-Wiederaufnahmehemmern in der Behandlung von Kindern und Jugendlichen im Vergleich zu Erwachsenen. Neuropsychiatrie 19, 34-39 (2005)